Cost-effectiveness analysis of comprehensive community intervention and health management of patients with dyslipidemia in Shenzhen
10.3760/cma.j.issn.1674-0815.2018.04.006
- VernacularTitle: 深圳市血脂异常人群社区健康管理成本效果评价研究
- Author:
Zhipeng ZHUO
1
;
Jin XIE
1
;
Xueli YUAN
1
;
Wenqing NI
1
;
Hongshan CHI
1
;
Jinping SONG
1
;
Hui YANG
1
;
Jian XU
1
Author Information
1. Shenzhen Center for Chronic Disease Control, Shenzhen 518020, China
- Publication Type:Journal Article
- Keywords:
Dyslipidemias;
Costs and cost analysis;
Economics;
Community health management
- From:
Chinese Journal of Health Management
2018;12(4):313-318
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the cost-effectiveness of intervention and management of the patients with dyslipidemia in some districts in Shenzhen and provide health economic basis for prevention and control of dyslipidemia.
Methods:We conducted a comprehensive community intervention among patients for dyslipidemia management, enrolling 204 cases of dyslipidemia in the intervention group and 200 cases in the control group through multi-stage cluster random sampling. We collected baseline and intervention data, such as the cost of institutional intervention (labor costs, office expenses, material expenses, loss of low-value consumables, service costs, and depreciation of fixed assets), patient costs (direct and indirect medical costs), effect indicators (lipid control rate, lipid improvement rate, and lipid exacerbation rate) to analyze cost-effectiveness.
Results:After 12 months of the comprehensive community intervention, the total cost for the intervention group was 1 321.62 yuan per capita; the cost per patient was 973.33 yuan; and per capita institutional cost was 348.29 yuan. Total cholesterol, triglyceide, and high-density lipoprotein cholesterol of intervention group decreased by 0.43 mmol/L, 0.16 mmol/L, and 0.42 mmol/L, respectively, after the intervention, and there was a significant difference before and after the intervention (P<0.05). After intervention, the intervention group lipid control rate was 17.6%, the lipid improvement rate was 48.0%, and the lipid exacerbation rate was 7.4%, whereas those of the control group were 10.5%, 22.5%, and 16.0%, respectively. The lipid control rate and improvement rate in the intervention group were higher than those in the control group, and the lipid exacerbation rate was lower than that of the control group. The difference between the two groups was statistically significant (χ2=43.774, P<0.001). Patients in the control group had a unit cost of 81.17 yuan for 1% of blood lipid control rate and 37.88 yuan for one unit of blood lipid improvement rate. The corresponding per capita cost of the intervention group was 74.87 yuan and 27.51 yuan, respectively. The intervention group's cost-effect ratio was lower than that of the control group and had good cost-effectiveness.
Conclusions:The comprehensive community intervention and management of patients with dyslipidemia was effective in terms of health economics and it is worth the long-term implementation and promotion in the community health service center.
